• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Antenatal corticosteroids may affect neurodevelopment differently based on gestational age

byMolly MunsellandAlex Gipsman, MD
April 28, 2022
in Chronic Disease, Neurology, Pediatrics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In a systematic review and meta-analysis of 30 cohort studies, antenatal corticosteroid use was associated with significantly decreased rates of later neurodevelopmental impairment in children born extremely preterm.

2. In children born late preterm or full term, exposure to antenatal corticosteroids was significantly associated with higher risk of adverse neurological and psychological outcomes.

Evidence Rating Level: 2 (Good)

Study Rundown: Antenatal corticosteroids (ACS) are used to foster fetal lung maturity and reduce neonatal mortality in the setting of likely preterm delivery. However, ACS use has been linked to negative effects on neurological development, which remain poorly understood. This review and meta-analysis assessed neurodevelopmental and psychological outcomes beyond 1 year of age using data from 30 cohort studies of over 1.25 million children. Based on 2 studies comparing children exposed to a single course of ACS to those unexposed, children born extremely premature were 31% less likely to have later neurodevelopmental impairment. Exposure to ACS was not associated with a significant difference in risk of impairment in the broader preterm population based on 5 studies. However, one study showed a significantly increased risk of neurocognitive disorders in children born late preterm (34-37 weeks), while another found significantly higher rates of mental or behavioral disorders and neurocognitive disorders in children born at full term who received ACS. This systematic review supports the positive impact of ACS on neurologic — not just overall — outcomes for extremely preterm infants, perhaps via reduced rates of neonatal complications such as intraventricular hemorrhage. However, it suggests that the harms of ACS may outweigh benefits in infants born later. Currently, administration of ACS to pregnant patients is recommended only before 34 weeks’ gestation, but predicting pregnancy and delivery courses to determine which infants will be delivered before this mark presents obvious difficulty.

Click to read the study in JAMA Pediatrics

Click to read an accompanying editorial in JAMA Pediatrics

Relevant Reading: Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth

RELATED REPORTS

Noninvasive ventilation with neurally adjusted ventilatory assist (NIV-NAVA) outperforms nasal continuous positive airway pressure (NCPAP) post-extubation in preterm infants

Rapid genotyping for variant associated with aminoglycoside-induced ototoxicity is feasible in acute neonatal setting

Very low birth weight associated with brain volume differences in adulthood

In-Depth [systematic review and meta-analysis]: Studies examining neurodevelopmental or psychological outcomes in children at least 1 year old born in or after 2000 who were exposed to ACS were included. Randomized controlled trials (RCTs) and quasi-RCTs were included in initial review but not the final study. The Newcastle-Ottawa scale was used to assess risk of bias; the median score was 5.75 out of 9, with 9 indicating highest comparability. The GRADE tool was used to rate the certainty of outcomes as high, moderate, low or very low. A random-effects meta-analysis was used for pooled outcomes. The adjusted odds ratio for neurodevelopmental impairment with ACS exposure was 0.69 [95% confidence interval (CI) 0.57-0.84], with low certainty but an I2 statistic of 0% indicating homogeneity of studies. For ACS-exposed children born at term, the hazard ratio for any mental or behavioral disorder was 1.47 (95% CI 1.36-1.60) and for any neurocognitive disorder was 1.16 (1.10-1.21), both with low certainty.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: antenatal steroidsneonatologyneurodevelopmentprematurity
Previous Post

#VisualAbstract: Neoadjuvant nivolumab plus chemotherapy increases event-free survival in resectable non-small-cell lung cancer

Next Post

Weight loss and lifestyle changes may improve symptoms of obstructive sleep apnea in overweight men

RelatedReports

No decrease in infant mortality with maternal micronutrient supplementation in Bangladesh
Pediatrics

Noninvasive ventilation with neurally adjusted ventilatory assist (NIV-NAVA) outperforms nasal continuous positive airway pressure (NCPAP) post-extubation in preterm infants

May 6, 2022
Oophorectomy associated with reduced cancer risk and all-cause mortality for BRCA1/2 patients
Genetics

Rapid genotyping for variant associated with aminoglycoside-induced ototoxicity is feasible in acute neonatal setting

April 6, 2022
Abusive head trauma results in fewer productive life-years
Chronic Disease

Very low birth weight associated with brain volume differences in adulthood

March 23, 2022
Racial, ethnic differences in outcomes of extremely preterm infants decreasing but persistent
Endocrinology

Enteral insulin reduces the duration of feeding intolerance in preterm infants

March 4, 2022
Next Post
Admission may not be needed following sleep apnea surgery

Weight loss and lifestyle changes may improve symptoms of obstructive sleep apnea in overweight men

#VisualAbstract: Dermatopathologists have varying perceptions on whether the overdiagnosis of different melanocytic skin lesions is a public health issue

#VisualAbstract: Dermatopathologists have varying perceptions on whether the overdiagnosis of different melanocytic skin lesions is a public health issue

Novel coronavirus identified from patients with pneumonia in Wuhan, China

Persistent and robust T-cell reactivity to the SARS-CoV-2 Omicron variant among immunized adults

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Severe actinic keratosis and need for additional treatment are markers for an increased risk of cutaneous squamous cell carcinoma
  • Virtual yoga and meditation intervention may be associated with increased health-related quality of life
  • Wellness Check: Mental Health
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.